{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:57:22Z","timestamp":1762459042935},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10096-012-1774-8","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:43:28Z","timestamp":1354189408000},"page":"557-564","source":"Crossref","is-referenced-by-count":19,"title":["Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B"],"prefix":"10.1007","volume":"32","author":[{"given":"R.","family":"Aguiar Cordeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. I.","family":"Mour\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F. G.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Farias Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E. C.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"Oliveira Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V. P.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S. N.","family":"Brilhante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jesus Pinheiro Gomes Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. C.","family":"Sidrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","volume":"60","author":"X Lin","year":"2006","unstructured":"Lin X, Heitman J (2006) The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 60:69\u2013105","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"1774_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50(3):291\u2013322","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1774_CR3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS 23(4):525\u2013530","journal-title":"AIDS"},{"issue":"9423","key":"1774_CR4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 363(9423):1764\u20131767","journal-title":"Lancet"},{"issue":"6","key":"1774_CR5","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/AAC.00153-10","volume":"54","author":"A Varma","year":"2010","unstructured":"Varma A, Kwon-Chung KJ (2010) Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother 54(6):2303\u20132311","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1774_CR6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jac\/dki393","volume":"56","author":"A Perkins","year":"2005","unstructured":"Perkins A, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M (2005) Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 56(6):1144\u20131147","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1774_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1439-0507.2006.01293.x","volume":"50","author":"CC Bii","year":"2007","unstructured":"Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, Revathi G, Wamae NC, Kamiya S (2007) Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. Mycoses 50(1):25\u201330","journal-title":"Mycoses"},{"issue":"7","key":"1774_CR8","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","volume":"53","author":"E Sionov","year":"2009","unstructured":"Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ (2009) Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother 53(7):2804\u20132815","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1774_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biomaterials.2009.09.087","volume":"31","author":"LR Martinez","year":"2010","unstructured":"Martinez LR, Mihu MR, Han G, Frases S, Cordero RJ, Casadevall A, Friedman AJ, Friedman JM, Nosanchuk JD (2010) The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31(4):669\u2013679","journal-title":"Biomaterials"},{"issue":"3","key":"1774_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/13693786.2011.609186","volume":"50","author":"D Steverding","year":"2012","unstructured":"Steverding D, Evans P, Msika L, Riley B, Wallington J, Schelenz S (2012) In vitro antifungal activity of DNA topoisomerase inhibitors. Med Mycol 50(3):333\u2013336","journal-title":"Med Mycol"},{"issue":"7","key":"1774_CR11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/jac\/dkr175","volume":"66","author":"PE Verwer","year":"2011","unstructured":"Verwer PE, Woodle MC, Boekhout T, Hagen F, Bakker-Woudenberg IA, van de Sande WW (2011) Cryptococcus and Trichosporon spp. are susceptible in vitro to branched histidine- and lysine-rich peptides (BHKPs). J Antimicrob Chemother 66(7):1649\u20131652","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"1774_CR12","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/AEM.02506-06","volume":"73","author":"LR Martinez","year":"2007","unstructured":"Martinez LR, Casadevall A (2007) Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol 73(14):4592\u20134601","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"1774_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10408410903241436","volume":"35","author":"G Ramage","year":"2009","unstructured":"Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35(4):340\u2013355","journal-title":"Crit Rev Microbiol"},{"issue":"11","key":"1774_CR14","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1128\/IAI.00995-06","volume":"74","author":"LR Martinez","year":"2006","unstructured":"Martinez LR, Casadevall A (2006) Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 74(11):6118\u20136123","journal-title":"Infect Immun"},{"issue":"3","key":"1774_CR15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","volume":"50","author":"LR Martinez","year":"2006","unstructured":"Martinez LR, Casadevall A (2006) Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 50(3):1021\u20131033","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"1774_CR16","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/AEM.01953-12","volume":"78","author":"EJ Robertson","year":"2012","unstructured":"Robertson EJ, Wolf JM, Casadevall A (2012) EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans. Appl Environ Microbiol 78(22):7977\u20137984","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"1774_CR17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1227\/00006123-198603000-00025","volume":"18","author":"TJ Walsh","year":"1986","unstructured":"Walsh TJ, Schlegel R, Moody MM, Costerton JW, Salcman M (1986) Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18(3):373\u2013375","journal-title":"Neurosurgery"},{"issue":"12","key":"1774_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/646675","volume":"14","author":"CW Ingram","year":"1993","unstructured":"Ingram CW, Haywood HB 3rd, Morris VM, Allen RL, Perfect JR (1993) Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. Infect Control Hosp Epidemiol 14(12):719\u2013722","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"1774_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/02681219780001031","volume":"35","author":"U Banerjee","year":"1997","unstructured":"Banerjee U, Gupta K, Venugopal P (1997) A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans. J Med Vet Mycol 35(2):139\u2013141","journal-title":"J Med Vet Mycol"},{"issue":"1","key":"1774_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.diagmicrobio.2009.01.005","volume":"64","author":"B Johannsson","year":"2009","unstructured":"Johannsson B, Callaghan JJ (2009) Prosthetic hip infection due to Cryptococcus neoformans: case report. Diagn Microbiol Infect Dis 64(1):76\u201379","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1\u20132","key":"1774_CR21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.vetmic.2011.06.038","volume":"154","author":"RA Cordeiro","year":"2011","unstructured":"Cordeiro RA, Costa AK, Brilhante RS, de Lima RA, Castelo-Branco Dde S, Ribeiro JF, Monteiro AJ, Rocha FA, Sidrim JJ, Rocha MF (2011) PCR-REA as an important tool for the identification of Cryptococcus neoformans and Cryptococcus gattii from human and veterinary sources. Vet Microbiol 154(1\u20132):180\u2013184","journal-title":"Vet Microbiol"},{"issue":"4","key":"1774_CR22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/JCM.01839-06","volume":"45","author":"A Enache-Angoulvant","year":"2007","unstructured":"Enache-Angoulvant A, Chandenier J, Symoens F, Lacube P, Bolognini J, Douchet C, Poirot JL, Hennequin C (2007) Molecular identification of Cryptococcus neoformans serotypes. J Clin Microbiol 45(4):1261\u20131265","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1774_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","volume":"9","author":"W Meyer","year":"2003","unstructured":"Meyer W, Casta\u00f1eda A, Jackson S, Huynh M, Casta\u00f1eda E; IberoAmerican Cryptococcal Study Group (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9(2):189\u2013195","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1774_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3314\/jjmm.48.47","volume":"48","author":"A Hanafy","year":"2007","unstructured":"Hanafy A, Uno J, Mitani H, Kang Y, Mikami Y (2007) In vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species. Jpn J Med Mycol 48(1):47\u201350","journal-title":"Jpn J Med Mycol"},{"key":"1774_CR25","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u2014third edition. CLSI document M27-A3. CLSI, Wayne, PA"},{"issue":"8","key":"1774_CR26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1590\/S0074-02762011000800024","volume":"106","author":"Rde A Cordeiro","year":"2011","unstructured":"Cordeiro Rde A, Astete-Medrano DJ, Marques FJ, Andrade HT, Perdig\u00e3o Neto LV, Tavares JL, de Lima RA, Patoilo KK, Monteiro AJ, Brilhante RS, Rocha MF, de Camargo ZP, Sidrim JJ (2011) Cotrimoxazole enhances the in vitro susceptibility of Coccidioides posadasii to antifungals. Mem Inst Oswaldo Cruz 106(8):1045\u20131048","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"1774_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11046-009-9245-1","volume":"169","author":"AK Costa","year":"2010","unstructured":"Costa AK, Sidrim JJ, Cordeiro RA, Brilhante RS, Monteiro AJ, Rocha MF (2010) Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil. Mycopathologia 169(3):207\u2013213","journal-title":"Mycopathologia"},{"key":"1774_CR28","first-page":"93","volume-title":"Medical mycology: cellular and molecular techniques","author":"GP Moran","year":"2007","unstructured":"Moran GP, Pinjon E, Coleman DC, Sullivan DJ (2007) Analysis of drug resistance in pathogenic fungi. In: Kavanagh K (ed) Medical mycology: cellular and molecular techniques. Wiley, Hoboken, pp 93\u2013113"},{"issue":"2","key":"1774_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","volume":"72","author":"E Peeters","year":"2008","unstructured":"Peeters E, Nelis HJ, Coenye T (2008) Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72(2):157\u2013165","journal-title":"J Microbiol Methods"},{"issue":"6","key":"1774_CR30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijantimicag.2006.07.012","volume":"28","author":"MD Navarro-Mart\u00ednez","year":"2006","unstructured":"Navarro-Mart\u00ednez MD, Cabezas-Herrera J, Rodr\u00edguez-L\u00f3pez JN (2006) Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans. Int J Antimicrob Agents 28(6):560\u2013567","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"1774_CR31","first-page":"342","volume":"46","author":"RC Hahn","year":"2003","unstructured":"Hahn RC, Morato Concei\u00e7\u00e3o YT, Santos NL, Ferreira JF, Hamdan JS (2003) Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole. Mycoses 46(8):342\u2013347","journal-title":"Mycoses"},{"issue":"9","key":"1774_CR32","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/AAC.00793-10","volume":"54","author":"RS Brilhante","year":"2010","unstructured":"Brilhante RS, Fechine MA, Cordeiro Rde A, Rocha MF, Ribeiro JF, Monteiro AJ, de Lima RA, Mesquita JR, de Camargo ZP, Sidrim JJ (2010) In vitro effect of sulfamethoxazole\u2013trimethoprim against Histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother 54(9):3978\u20133979","journal-title":"Antimicrob Agents Chemother"},{"key":"1774_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2652-15-1","volume":"15","author":"PL Lim","year":"2012","unstructured":"Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database (2012) Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database. J Int AIDS Soc 15:1","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"1774_CR34","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JCM.43.8.3807-3810.2005","volume":"43","author":"MA Pfaller","year":"2005","unstructured":"Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ (2005) In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods. J Clin Microbiol 43(8):3807\u20133810","journal-title":"J Clin Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-012-1774-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1774-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:03Z","timestamp":1559122503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-012-1774-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s10096-012-1774-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}